Ribonucleases endowed with specific toxicity for spermatogenic layers.

Area of Science:

• Biochemistry
• Reproductive Biology
• Enzymology

Background:

• Bovine seminal ribonuclease (BS-RNase) is a disulfide-linked dimer resistant to ribonuclease inhibitor (RI).
• Dimeric BS-RNase exhibits cytotoxicity, while monomeric forms are inhibited by RI.
• Understanding structural modifications can alter BS-RNase properties and cellular interactions.

Purpose of the Study:

• To investigate the effects of specific carboxymethylation modifications on BS-RNase.
• To assess the resistance of modified BS-RNase variants (MCM31, MCM32) to RI.
• To evaluate the cytotoxic and aspermatogenic potential of these modified enzymes.

Main Methods:

• Chemical modification of BS-RNase at cysteine residues (C31, C32) to create MCM31 and MCM32.
• Assays to determine resistance to ribonuclease inhibitor (RI).
• In vivo studies in mice to assess aspermatogenic effects and toxicity.
• Immunofluorescence to identify target cells of modified BS-RNase.

Main Results:

• MCM31 and MCM32 are resistant to RI.
• MCM31 and MCM32 induce aspermatogenesis specifically in spermatogenic cells.
• These modified enzymes do not affect other cell types or general testicular structure.
• MCM31 and MCM32 bind selectively to spermatogonia and primary spermatocytes.

Conclusions:

• Carboxymethylation of BS-RNase yields variants (MCM31, MCM32) with diminished RI affinity and specific aspermatogenic activity.
• The cell-specific binding of MCM31 and MCM32 to early spermatogenic cells suggests targeted reproductive effects.
• These properties make MCM31 and MCM32 promising candidates for novel contraceptive strategies and seminoma therapies.